Literature DB >> 26646560

Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma.

Melissa L Cooper1, Samuel D Crish2, Denise M Inman2, Philip J Horner3, David J Calkins4.   

Abstract

Glaucoma challenges the survival of retinal ganglion cell axons in the optic nerve through processes dependent on both aging and ocular pressure. Relevant stressors likely include complex interplay between axons and astrocytes, both in the retina and optic nerve. In the DBA/2J mouse model of pigmentary glaucoma, early progression involves axonopathy characterized by loss of functional transport prior to outright degeneration. Here we describe novel features of early pathogenesis in the DBA/2J nerve. With age the cross-sectional area of the nerve increases; this is associated generally with diminished axon packing density and survival and increased glial coverage of the nerve. However, for nerves with the highest axon density, as the nerve expands mean cross-sectional axon area enlarges as well. This early expansion was marked by disorganized axoplasm and accumulation of hyperphosphorylated neurofilamants indicative of axonopathy. Axon expansion occurs without loss up to a critical threshold for size (about 0.45-0.50 μm(2)), above which additional expansion tightly correlates with frank loss of axons. As well, early axon expansion prior to degeneration is concurrent with decreased astrocyte ramification with redistribution of processes towards the nerve edge. As axons expand beyond the critical threshold for loss, glial area resumes an even distribution from the center to edge of the nerve. We also found that early axon expansion is accompanied by reduced numbers of mitochondria per unit area in the nerve. Finally, our data indicate that both IOP and nerve expansion are associated with axon enlargement and reduced axon density for aged nerves. Collectively, our data support the hypothesis that diminished bioenergetic resources in conjunction with early nerve and glial remodeling could be a primary inducer of progression of axon pathology in glaucoma.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocyte; Axonopathy; Glaucoma; Gliosis; Neurodegeneration; Retinal ganglion cell

Mesh:

Year:  2015        PMID: 26646560      PMCID: PMC4889569          DOI: 10.1016/j.exer.2015.11.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  49 in total

1.  Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve.

Authors:  Sophie C Payne; Carole A Bartlett; Alan R Harvey; Sarah A Dunlop; Melinda Fitzgerald
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-04       Impact factor: 4.799

Review 2.  Structural remodeling of astrocytes in the injured CNS.

Authors:  Daniel Sun; Tatjana C Jakobs
Journal:  Neuroscientist       Date:  2011-10-07       Impact factor: 7.519

3.  Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma.

Authors:  Denise M Inman; Rebecca M Sappington; Philip J Horner; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  Distal axonopathy with structural persistence in glaucomatous neurodegeneration.

Authors:  Samuel D Crish; Rebecca M Sappington; Denise M Inman; Philip J Horner; David J Calkins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

5.  Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration.

Authors:  Selva Baltan; Denise M Inman; Camelia A Danilov; Richard S Morrison; David J Calkins; Philip J Horner
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

6.  Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis.

Authors:  Rebecca M Sappington; David A Pearce; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

7.  Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.

Authors:  Maher Saleh; Mahesh Nagaraju; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice.

Authors:  Michael Scholz; Thomas Buder; Silke Seeber; Edyta Adamek; Cord-Michael Becker; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

Review 9.  From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma.

Authors:  Robert W Nickells
Journal:  Can J Ophthalmol       Date:  2007-04       Impact factor: 1.882

10.  Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice.

Authors:  Tatjana C Jakobs; Richard T Libby; Yixin Ben; Simon W M John; Richard H Masland
Journal:  J Cell Biol       Date:  2005-10-24       Impact factor: 10.539

View more
  35 in total

Review 1.  The challenge of regenerative therapies for the optic nerve in glaucoma.

Authors:  David J Calkins; Milos Pekny; Melissa L Cooper; Larry Benowitz
Journal:  Exp Eye Res       Date:  2017-01-30       Impact factor: 3.467

Review 2.  Astrocyte structural reactivity and plasticity in models of retinal detachment.

Authors:  Gabriel Luna; Patrick W Keeley; Benjamin E Reese; Kenneth A Linberg; Geoffrey P Lewis; Steven K Fisher
Journal:  Exp Eye Res       Date:  2016-04-06       Impact factor: 3.467

3.  Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma.

Authors:  Alejandra Bosco; Kevin T Breen; Sarah R Anderson; Michael R Steele; David J Calkins; Monica L Vetter
Journal:  Exp Eye Res       Date:  2016-02-03       Impact factor: 3.467

4.  Age-related accumulation of phosphorylated mitofusin 2 protein in retinal ganglion cells correlates with glaucoma progression.

Authors:  Mary P Nivison; Nolan G Ericson; Virginia M Green; Jason H Bielas; Jean S Campbell; Philip J Horner
Journal:  Exp Neurol       Date:  2017-07-03       Impact factor: 5.330

Review 5.  The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.

Authors:  Hongli Yang; Juan Reynaud; Howard Lockwood; Galen Williams; Christy Hardin; Luke Reyes; Cheri Stowell; Stuart K Gardiner; Claude F Burgoyne
Journal:  Prog Retin Eye Res       Date:  2017-03-12       Impact factor: 21.198

6.  Optic Nerve Head Myelin-Related Protein, GFAP, and Iba1 Alterations in Non-Human Primates With Early to Moderate Experimental Glaucoma.

Authors:  Priya Chaudhary; Cheri Stowell; Juan Reynaud; Stuart K Gardiner; Hongli Yang; Galen Williams; Imee Williams; Nicholas Marsh-Armstrong; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

7.  Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model.

Authors:  Shouyue Huang; Ping Huang; Xi Shen; Yisheng Zhong; Huan Yu; Junjue Chen; Xiaohong Liu; Jing Wang
Journal:  Cell Tissue Res       Date:  2022-05-20       Impact factor: 4.051

Review 8.  Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration.

Authors:  Andrew M Boal; Michael L Risner; Melissa L Cooper; Lauren K Wareham; David J Calkins
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

Review 9.  Adaptive responses to neurodegenerative stress in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 19.704

10.  Transcorneal Electrical Stimulation Reduces Neurodegenerative Process in a Mouse Model of Glaucoma.

Authors:  Assraa Hassan Jassim; McKay Cavanaugh; Jessica Stukel Shah; Rebecca Willits; Denise M Inman
Journal:  Ann Biomed Eng       Date:  2020-09-24       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.